Jie Fang

Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor

Shondra M. Pruett-Miller, H. Tan, V. Pagala, 2024, eLife.

Metabolic reprogramming of cancer cells by JMJD 6-mediated pre-mRNA splicing is associated 1 with therapeutic response to splicing inhibitor 2 3

Shondra M. Pruett-Miller, Ji-Hoon Cho, D. Finkelstein, 2023 .

Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro

P. Duerksen-Hughes, C. Casiano, S. Dovat, 2024, International journal of molecular sciences.

Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinoma

Xiaotu Ma, D. Picketts, Tingting Wang, 2024, bioRxiv.

The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven cancer

Shondra M. Pruett-Miller, Shi Wan, Shivendra Singh, 2024, Research square.